|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medical Chemistry, Biochemistry, and Biotechnology, Center of Excellence on Neurodegenerative Diseases, University of Milan, Segrate, Italy
2 To whom correspondence should be addressed. e-mail: alessandro.prinetti{at}unimi.it
Treatment with methyl-ß-cyclodextrin (MCD) induced a time- and dose-dependent efflux of cholesterol, sphingolipids, and phosphatidylcholine (PC) from cerebellar neurons differentiated in culture. With a "mild" treatment, the loss of cell lipids induced a deep reorganization of the remaining membrane lipids. In fact, the amount of PC associated with a Triton X-100-insoluble membrane fraction (highly enriched in sphingolipids and cholesterol in nontreated cells) was lowered by the treatment. This suggested a reduction of the lipid domain area. However, the cholesterol and sphingolipid enrichment of this fraction remained substantially unchanged, suggesting the existence of dynamic processes aimed at preserving the segregation of cholesterol and sphingolipids in membrane domains. Under these conditions, the lipid membrane domains retained the ability to sort signaling proteins, such as Lyn and c-Src, but cells displayed deep alterations in their membrane permeability. However, normal membrane permeability was restored by loading cells with cholesterol. When MCD treatment was more stringent, a large loss of cell lipids occurred, and the lipid domains were much less enriched in cholesterol and lost the ability to sort specific proteins.
The loss of the integrity and properties of lipid domains was accompanied by severe changes in the membrane permeability, distress, and eventually cell death.
Abbreviations: BME, basal modified Eagle's medium; HPTLC, high-performance thin-layer chromatography; [1-3H]sphingosine, (2S,3R,4E)-2-amino-1,3-dihydroxy-[1-3H]octadecene; MCD, methyl-ß-cyclodextrin; MTT, 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyltetrazolium bromide; PC, phosphatidylcholine; SM, sphingomyelin
Supplementary key words cholesterol sphingomyelin ganglioside sphingolipid-enriched membrane domain cyclodextrin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Thammacharoen, T. A. Lutz, N. Geary, and L. Asarian Hindbrain Administration of Estradiol Inhibits Feeding and Activates Estrogen Receptor-{alpha}-Expressing Cells in the Nucleus Tractus Solitarius of Ovariectomized Rats Endocrinology, April 1, 2008; 149(4): 1609 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tikku, Y. Epshtein, H. Collins, A. J. Travis, G. H. Rothblat, and I. Levitan Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains Am J Physiol Cell Physiol, July 1, 2007; 293(1): C440 - C450. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Escartin, E. Brouillet, P. Gubellini, Y. Trioulier, C. Jacquard, C. Smadja, G. W. Knott, L. K.-L. Goff, N. Deglon, P. Hantraye, et al. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J. Neurosci., May 31, 2006; 26(22): 5978 - 5989. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Riff, J. W. Callahan, and P. M. Sherman Cholesterol-Enriched Membrane Microdomains Are Required for Inducing Host Cell Cytoskeleton Rearrangements in Response to Attaching-Effacing Escherichia coli Infect. Immun., November 1, 2005; 73(11): 7113 - 7125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toselli, G. Biella, V. Taglietti, E. Cazzaniga, and M. Parenti Caveolin-1 Expression and Membrane Cholesterol Content Modulate N-Type Calcium Channel Activity in NG108-15 Cells Biophys. J., October 1, 2005; 89(4): 2443 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sandhoff, R. Geyer, R. Jennemann, C. Paret, E. Kiss, T. Yamashita, K. Gorgas, T. P. Sijmonsma, M. Iwamori, C. Finaz, et al. Novel Class of Glycosphingolipids Involved in Male Fertility J. Biol. Chem., July 22, 2005; 280(29): 27310 - 27318. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hinkovska-Galcheva, L. A. Boxer, A. Kindzelskii, M. Hiraoka, A. Abe, S. Goparju, S. Spiegel, H. R. Petty, and J. A. Shayman Ceramide 1-Phosphate, a Mediator of Phagocytosis J. Biol. Chem., July 15, 2005; 280(28): 26612 - 26621. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli, and E. Monflier Behavior of {alpha}-, {beta}-, and {gamma}-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |